Adaptive Biotechnologies Corp. (ADPT)
28.35
+0.98
(+3.58%)
USD |
NASDAQ |
Oct 02, 16:00
28.34
-0.02
(-0.05%)
After-Hours: 20:00
Adaptive Biotechnologies Price : 28.35 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 27.59 | 28.41 | 27.31 | 28.35 | 1.575M |
| Oct 01, 2026 | 28.88 | 29.00 | 27.14 | 27.37 | 6.019M |
| Sep 30, 2026 | 28.80 | 29.52 | 28.75 | 28.90 | 1.508M |
| Sep 29, 2026 | 29.28 | 29.80 | 28.63 | 28.77 | 2.508M |
| Sep 28, 2026 | 29.00 | 29.52 | 28.07 | 28.51 | 2.639M |
| Sep 25, 2026 | 29.96 | 29.96 | 28.88 | 29.43 | 1.686M |
| Sep 24, 2026 | 28.00 | 29.58 | 27.50 | 29.57 | 3.610M |
| Sep 23, 2026 | 27.74 | 28.35 | 27.60 | 27.89 | 1.080M |
| Sep 22, 2026 | 27.30 | 28.36 | 26.73 | 28.06 | 4.000M |
| Sep 21, 2026 | 28.69 | 28.78 | 27.70 | 27.86 | 1.459M |
| Sep 18, 2026 | 28.55 | 28.68 | 27.91 | 28.61 | 2.986M |
| Sep 17, 2026 | 28.23 | 28.72 | 27.77 | 28.55 | 3.280M |
| Sep 16, 2026 | 27.09 | 28.72 | 27.03 | 27.67 | 5.026M |
| Sep 15, 2026 | 24.80 | 27.34 | 24.71 | 26.68 | 4.124M |
| Sep 14, 2026 | 24.26 | 24.88 | 23.96 | 24.78 | 1.730M |
| Sep 11, 2026 | 24.23 | 24.79 | 23.93 | 24.20 | 1.238M |
| Sep 10, 2026 | 23.81 | 24.65 | 23.53 | 24.23 | 1.071M |
| Sep 09, 2026 | 24.05 | 24.68 | 23.89 | 24.42 | 1.107M |
| Sep 08, 2026 | 23.98 | 24.60 | 23.62 | 24.34 | 1.359M |
| Sep 04, 2026 | 24.06 | 24.40 | 23.94 | 24.28 | 1.404M |
| Sep 03, 2026 | 25.18 | 25.36 | 23.84 | 24.57 | 2.161M |
| Sep 02, 2026 | 24.40 | 25.23 | 24.18 | 24.66 | 1.623M |
| Sep 01, 2026 | 24.91 | 25.11 | 24.20 | 24.34 | 1.621M |
| Aug 31, 2026 | 24.61 | 25.02 | 23.86 | 24.92 | 2.238M |
| Aug 28, 2026 | 26.54 | 26.58 | 25.13 | 25.19 | 1.509M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Personalis, Inc. | 16.28 |
| 10X Genomics, Inc. | 93.50 |
| Alamar Biosciences, Inc. (California) | 34.36 |
| Champions Oncology, Inc. | 4.94 |
| Medpace Holdings, Inc. | 599.47 |
Price Related Metrics
| PS Ratio | 14.53 |
| Price to Book Value | 31.55 |
| Earnings Yield | -1.44% |
| Market Cap | 4.509B |